Steroids, diabetes, . . . and other stories
BMJ 2019; 365 doi: https://doi.org/10.1136/bmj.l4290 (Published 27 June 2019) Cite this as: BMJ 2019;365:l4290Topical steroid use and type 2 diabetes
Treatment with glucocorticosteroids is well known to precipitate type 2 diabetes. A series of population based studies from the UK and Denmark finds that this is true even for topical preparations used to treat inflammatory skin conditions such as eczema and psoriasis (Diabetes Care doi:10.2337/dc18-2158). People who had been prescribed topical corticosteroids had a roughly 25% increased risk of developing type 2 diabetes, and the risk was higher if they received more potent preparations. But in absolute terms the hazard is small—the equivalent of two extra cases of diabetes for every 1000 people exposed. …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.